Stocks · Health care · Biological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc.

DNA Clue Score24
United States Fiscal year ends December CIK 0001830214 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jason R Kelly
8 Apr 2026
See remarks
Sold after exercise
97,015
$6.93
$672.31K
Barry Canton
8 Apr 2026
10% owner
Sold after exercise
13,155
$6.93
$91.16K
Reshma P. Shetty
8 Apr 2026
See remarks
Sold after exercise indirect
13,155
$6.93
$91.16K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 1,358,729
History held since 20 Sep 2021